GlassScriptPhysician profile
Laura B Willard
NPI 1700314754
$4,134.10
in general payments reported to CMS, 2019-2025
23 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what 85% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $539 · 2022: $1,161 · 2023: $748 · 2024: $672 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $564.32 | 2022-2025 | Atriclip Laa Exclusion System |
| Abiomed | $489.87 | 2022-2025 | Impella |
| Janssen Pharmaceuticals, INC | $423.26 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $323.06 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $309.39 | 2021-2025 | Verquvo, Capvaxive |
| Cvrx, INC. | $272.78 | 2024-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $215.42 | 2021-2025 | |
| Pfizer INC. | $184.70 | 2021-2025 | |
| Cardiva Medical, INC. | $172.51 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $166.38 | 2021-2024 | Wainua, Farxiga |
| Boston Scientific Corporation | $149.16 | 2025 | Watchman Flx |
| Medtronic, INC. | $132.84 | 2022-2024 | Corevalve Evolut R |
| Abbott Laboratories | $125.57 | 2021-2023 | Assurity |
| E.R. Squibb & Sons, L.L.C. | $125.40 | 2022-2023 | Eliquis |
| Lexicon Pharmaceuticals, INC. | $78.78 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60.44 | 2021-2023 | Repatha |
| Alnylam Pharmaceuticals INC. | $59.08 | 2023-2024 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $58.26 | 2023-2025 | |
| Chiesi USA, INC. | $58.13 | 2021-2022 | |
| Gilead Sciences, INC. | $53.66 | 2023 | |
| Daiichi Sankyo INC. | $53.64 | 2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.76 | 2022 | |
| Edwards Lifesciences Corporation | $20.69 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Willard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.